# Tachykinergic signaling mediated by NK1 receptors in the respiratory parafacial region drives respiratory output and contributes to the chemoreflex response to CO2

**Authors:** Octávio A. C. Maia, Luiz M. Oliveira, Jan-Marino Ramirez, Ana C. Takakura, Thiago S. Moreira

PMC · DOI: 10.1007/s00424-025-03147-8 · Pflugers Archiv · 2026-01-23

## TL;DR

This study shows that tachykinergic signaling in the pFRG region boosts breathing and helps the body respond to CO2 changes.

## Contribution

The study reveals a novel role of NK1 receptors in modulating respiratory output and CO2 chemoreflex via tachykinin signaling in the pFRG.

## Key findings

- Substance P microinjection into the pFRG increases respiratory parameters, which are blocked by NK1 antagonists.
- Blocking NK1 receptors in the pFRG reduces the respiratory response to CO2.
- Optogenetic stimulation of Tac1 neurons in the pFRG increases respiratory rate and motor output.

## Abstract

The respiratory parafacial region (pFRG) contributes critically to central chemoreception, CO2/H+ homeostasis and the regulation of all major components of the respiratory rhythm. The respiratory rhythm is also modulated by the neuropeptide substance P which is released by tachykinin-1 (Tac1)- expressing neurons. However, how tachykinergic signaling modulates the pFRG region remains incompletely understood. Here we show that substance P (1 µM, 30 nL) microinjected into the ventral pFRG increased respiratory frequency, amplitude, and minute volume under baseline conditions. These excitatory effects were abolished by prior application of the NK1 receptor antagonist GR82334, confirming NK1-mediated effect. Bilateral blockade of NK1 receptors in the ventral pFRG significantly attenuated hypercapnia-induced (FiCO2= 0.07) increases in respiratory parameters, suggesting tachykinergic signaling in CO2 chemoreflex responses. Immunohistochemical analysis revealed a predominant co-localization of NK1 receptors with VGlut2-expressing glutamatergic neurons in the ventral pFRG, whereas minimal co-expression was found with GABAergic neurons. To directly assess the function of tachykinin-producing neurons, we optogenetically stimulated Tac1-expressing neurons in the ventral pFRG. Light activation produced immediate increases in respiratory rate and motor output. These findings demonstrate that tachykinin signaling in the ventral pFRG enhances respiratory output. Tac1-expressing neurons may function as an integrative hub for coordinating respiratory functions under baseline and chemoreflex conditions.

## Linked entities

- **Genes:** TAC1 (tachykinin precursor 1) [NCBI Gene 6863], SLC17A6 (solute carrier family 17 member 6) [NCBI Gene 57084]

## Full-text entities

- **Genes:** Sp5 (trans-acting transcription factor 5) [NCBI Gene 64406], Chat (choline O-acetyltransferase) [NCBI Gene 12647] {aka B230380D24Rik, CHOACTase}, Th (tyrosine hydroxylase) [NCBI Gene 21823], Nmb (neuromedin B) [NCBI Gene 68039] {aka 3110023K12Rik}, Slc32a1 (solute carrier family 32 (GABA vesicular transporter), member 1) [NCBI Gene 22348] {aka VGAT, Viaat}, Tac1 (tachykinin 1) [NCBI Gene 21333] {aka 4930528L02Rik, NK-1, NK1, Nkna, PPT-A, PPTA}, Phox2b (paired-like homeobox 2b) [NCBI Gene 18935] {aka Dilp1, NBPhox, Pmx2b, Px2b}, Nalcn (sodium leak channel, non-selective) [NCBI Gene 338370] {aka A530023G15Rik, Vgcnl1}, Hspg2 (perlecan (heparan sulfate proteoglycan 2)) [NCBI Gene 15530] {aka HSPG, Pcn, Plc, per}, Tff2 (trefoil factor 2 (spasmolytic protein 1)) [NCBI Gene 21785] {aka SP, mSP}, Slc17a6 (solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6) [NCBI Gene 140919] {aka 2900073D12Rik, DNPI, VGLUT2}, Tacr1 (tachykinin receptor 1) [NCBI Gene 21336] {aka Nk1r, Spr, Tac1r}, Htr2a (5-hydroxytryptamine (serotonin) receptor 2A) [NCBI Gene 15558] {aka 5-HT-2, 5-HT-2A, E030013E04, Htr-2, Htr2}, Unc80 (unc-80, NALCN activator) [NCBI Gene 329178] {aka C030018G13Rik, C230061B10Rik, UNC-80}, Tacr1 (tachykinin receptor 1) [NCBI Gene 24807] {aka Tac1r}, Eif1a (eukaryotic translation initiation factor 1A) [NCBI Gene 13664] {aka Ef1a, Eftu, Eif4c, eIF-1A, eIF-4C}
- **Diseases:** congenital central hypoventilation syndrome (MESH:C536209), Hypercapnia (MESH:D006935), hypercapnic (MESH:D012131), pain (MESH:D010146), hypoventilation (MESH:D007040), hypoxia (MESH:D000860)
- **Chemicals:** urethane (MESH:D014520), Alexa 647 (MESH:C569686), Na+ (MESH:D012964), AAV1 (-), Alexa 594 (MESH:C417664), heparin (MESH:D006493), nitrogen (MESH:D009584), Co (MESH:D003035), formaldehyde (MESH:D005557), ethylene glycol (MESH:D019855), isoflurane (MESH:D007530), saline (MESH:D012965), H+ (MESH:D006859), latex (MESH:D007840), silver (MESH:D012834), xylazine (MESH:D014991), CO2 (MESH:D002245), 5-HT (MESH:D012701), PB (MESH:D007854), tetrodotoxin (MESH:D013779), DPX (MESH:C027512), glycerol (MESH:D005990), K+ (MESH:D011188), phosphate (MESH:D010710)
- **Species:** Gallus gallus (bantam, species) [taxon 9031], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** H134R
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12827308/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12827308/full.md

---
Source: https://tomesphere.com/paper/PMC12827308